Your session is about to expire
← Back to Search
Acupuncture for Epilepsy
N/A
Recruiting
Led By Olga Rodziyevska, MS,PA-C
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month after last treatment
Awards & highlights
Study Summary
This trial will study the effects of acupuncture on mood, cognition, seizure frequency, and severity in patients with epilepsy.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 month after last treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month after last treatment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Changes in seizure severity
Seizures
Secondary outcome measures
Average number of detections of seizures per-day (as stored by the RNS System)
Change in cognition and mood as assessed by the Generalized Anxiety Disorder 7-item (GAD-7) scale
Change in cognition and mood as assessed by the Patient Health Questionnaire (PHQ-9)
+1 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Experimental groupExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
The University of Texas Health Science Center, HoustonLead Sponsor
909 Previous Clinical Trials
323,527 Total Patients Enrolled
6 Trials studying Epilepsy
383 Patients Enrolled for Epilepsy
Olga Rodziyevska, MS,PA-CPrincipal InvestigatorThe University of Texas Health Science Center, Houston
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a medical device called the RNS system implanted in your body.You are able to have acupuncture treatments for 12 weeks.You can keep the same settings for your medical devices for at least 12 weeks.
Research Study Groups:
This trial has the following groups:- Group 1: Experimental group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger